Absci announces proposed public offering of common stock

Vancouver, wash., feb. 27, 2024 (globe newswire) -- absci corporation (nasdaq: absi) (“absci”), a data-first generative ai drug creation company, announced today that it has commenced an underwritten public offering of $75.0 million of shares of its common stock. absci also intends to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of shares of its common stock. all of the shares in the proposed offering are to be sold by absci.
ABSI Ratings Summary
ABSI Quant Ranking